1 1

PI5P4K-β-IN-1 [CAS 332407-28-0]

PI5P4K-β-IN-1 [CAS 332407-28-0]

Size

QM-0068372

Price on request

Request quote or documents

View full details

Product Details

  • Description

    PI5P4K-β-IN-1 (compound vs1) is a potent inhibitor of PI5P4K-β (IC50: 0.80 μM) [1].

  • CAS Number

    [332407-28-0]

  • Molecular Formula

    C23H17Cl2N3O2

  • Molecular Weight

    438.31

  • Smiles

    ClC1=CC=C(COC2=CC=CC(/C=C3C(NC(NC4=CC=CC=C4)=N\3)=O)=C2)C(Cl)=C1

  • Target

    PI5P4K

  • Solubility

    10 mM in DMSO

  • Shipping Conditions

    Room temperature
Learn more
Variant Variant total Quantity Price Variant total
1 EachQM-0068372
1 EachQM-0068372
£0.00/ea		 £0.00
£0.00/ea £0.00

Related Products

Other industry favorites

PI5P4K-β-IN-1 [CAS 332407-28-0]

PI5P4K-β-IN-1 for PI5P4K-β Inhibition and Lipid-Kinase Research

PI5P4K-β-IN-1, also described in the literature as compound vs1, is a small-molecule PI5P4K-β inhibitor used as a research tool in phosphoinositide signaling, lipid-kinase biology, cancer-metabolism studies, and computational hit-identification workflows.

Research context

PI5P4K enzymes, also known as type II phosphatidylinositol 5-phosphate 4-kinases or PIP4Ks, regulate phosphoinositide signaling through phosphorylation of PI(5)P. PI5P4K-β has been investigated as a metabolic signaling node and as a target in cancer-focused kinase research.

This product page already lists the core compound identifiers, including CAS number, formula, molecular weight, SMILES, target, solubility, and shipping condition. The information below is intended to add application context, search visibility, and selection guidance without duplicating the full identity table.

PI5P4K-β-IN-1 PI5P4K beta inhibitor PIP4K2B research compound vs1 CAS 332407-28-0 phosphoinositide kinase PI(5)P signaling lipid kinase inhibitor CADD hit compound

How researchers use this compound

  • As a PI5P4K-β inhibitor reference compound in biochemical or enzyme-assay development.
  • For comparing PI5P4K-pathway perturbation against genetic or orthogonal chemical approaches.
  • As a tool compound in phosphoinositide signaling, lipid second-messenger, and cancer-metabolism research.
  • As a literature-linked example from AI- and computational chemistry-driven hit-identification studies.

Selection notes for laboratory teams

  • Use CAS 332407-28-0 and the listed SMILES string when matching compound records across procurement, inventory, and assay documentation.
  • DMSO is commonly used for stock preparation; validate final solvent percentage for each assay system.
  • Confirm storage, retest date, and handling conditions against the batch-specific CoA and SDS before use.
  • Avoid interpreting in vitro inhibition values as evidence of clinical activity or therapeutic suitability.
Safety and handling: No product-page H phrases or P phrases are listed here. Confirm hazard classification, personal protective equipment, disposal route, and exposure controls against the batch-specific SDS. Do not place hazard statements in the precautionary-statement field.

FAQ

What is PI5P4K-β-IN-1 used for?

PI5P4K-β-IN-1 is used as a laboratory research compound for studying PI5P4K-β inhibition, phosphoinositide signaling, lipid-kinase biology, and target-validation workflows.

Is PI5P4K-β-IN-1 the same as compound vs1?

Yes. The research literature and product descriptions identify PI5P4K-β-IN-1 as compound vs1 in the PI5P4K-β hit-identification context.

Can PI5P4K-β-IN-1 be used in biological assays?

It may be used in appropriately designed laboratory assays, subject to solubility, concentration, solvent tolerance, and assay-format validation by the research team.

Does this compound have clinical or diagnostic use?

No. This compound is supplied for laboratory research use only and should not be used for human, veterinary, food, drug, diagnostic, or household applications.

Neutral references

For laboratory research use only. Not for human, veterinary, food, drug, or household use.